Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population

Journal of Receptors and Signal Transduction

Volumn 34, Issue 3, 2014, Pages 180-184

  Zhou, Tian Biao ^a   Guo, Xue Feng ^a   Yin, Sheng Sheng ^a  

^a THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Gene polymorphism; Meta analysis; PPAR ; Pro12Ala; Type 2 diabetic nephropathy

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; GENETIC MARKER;

ALLELE; ARTICLE; CAUCASIAN; COCHRANE LIBRARY; DIABETIC NEPHROPATHY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK POPULATION; HUMAN; MEDLINE; META ANALYSIS (TOPIC); POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SENSITIVITY ANALYSIS; TYPE 2 DIABETIC NEPHROPATHY; ETHNOLOGY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; META ANALYSIS; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICS AND NUMERICAL DATA;

DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; RISK FACTORS;

EID: 84901288306     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2013.868905     Document Type: Article

References (22)

1. Zhou TB, Drummen GP, Jiang ZP, et al. Association of peroxisome proliferator-Activated receptors/retinoic acid receptors with renal diseases. J Recept Signal Transduct Res 2013. [Epub ahead of print
2. Tsukahara T, Haniu H, Matsuda Y. PTB-Associated splicing factor (PSF) is a PPARgamma-binding protein and growth regulator of colon cancer cells. PLoS One 2013;8:e58749
3. Takada I, Yogiashi Y, Kato S. Signaling crosstalk between PPARgamma and BMP2 in mesenchymal stem cells. PPAR Res 2012;2012:607141
4. Zhou TB, Ou C, Luo CP, Xu HL. Protective effects of PPARgamma agonist in glomerulosclerosis rats induced by adriamycin. Ren Fail 2012;34:940-1
5. Okunuki Y, Usui Y, Nakagawa H, et al. Peroxisome proliferatoractivated receptor-gamma agonist pioglitazone suppresses experimental autoimmune uveitis. Exp Eye Res 2013;116:291-7
6. Nakhoul F, Nakhoul N, Asleh R, et al. Is the Hp 2-2 diabetic mouse model a good model to study diabetic nephropathy? Diabetes Res Clin Pract 2013;100:289-97
7. Khajehdehi P, Pakfetrat M, Javidnia K, et al. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-beta and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: A randomized, double-blind and placebo-controlled study. Scand J Urol Nephrol 2011;45:365-70
8. Zhou TB, Yin SS. Association of matrix metalloproteinase-9 level with the risk of renal involvement for Henoch-Schonlein purpura in children. Ren Fail 2013;35:425-9
9. Zhou TB, Yin SS, Liang R. A meta-Analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients. J Renin Angiotensin Aldosterone Syst 2013;14:235-41
10. Cheng HY, You HY, Zhou TB. Relationship between GSTM1/ GSTT1 null genotypes and renal cell carcinoma risk: A metaanalysis. Ren Fail 2012;34:1052-7
11. Zhou TB, Qin YH, Xu HL. Association of apoE gene expression and its gene polymorphism with nephrotic syndrome susceptibility: A meta-Analysis of experimental and human studies. Mol Biol Rep 2012;39:9347-54
12. Zhou TB, Yin SS. Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease. Ren Fail 2013;35:573-8
13. Zhou TB, Yin SS, Jiang ZP. Association of angiotensin II type-1 receptor A1166C gene polymorphism with the susceptibility of end-stage renal disease. J Recept Signal Transduct Res 2013;33: 325-31
14. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50: 1088-101
15. Caramori ML, Canani LH, Costa LA, Gross JL. The human peroxisome proliferator-Activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes. Diabetes 2003;52: 3010-3. (Pubitemid 37466874
16. De Cosmo S, Motterlini N, Prudente S, et al. Impact of the PPARgamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: Evidence from BENEDICT. Diabetes 2009;58:2920-9
17. De Cosmo S, Prudente S, Lamacchia O, et al. PPARgamma2 P12A polymorphism and albuminuria in patients with type 2 diabetes: A meta-Analysis of case-control studies. Nephrol Dial Transplant 2011;26:4011-6
18. Herrmann SM, Ringel J, Wang JG, et al. Peroxisome proliferatoractivated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study. Diabetes. 2002;51:2653-7. (Pubitemid 34827420
19. Lapice E, Pinelli M, Riccardi G, Vaccaro O. Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients: Comment on the study by Liu et al. Diabetes Care 2010;33:e114; author reply e5
20. Pollex RL, Mamakeesick M, Zinman B, et al. Peroxisome proliferator-Activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes. J Diabetes Complications 2007;21:166-71. (Pubitemid 46687068
21. Wang L, Teng Z, Cai S, et al. The association between the PPARgamma2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: A meta-Analysis based on 9,176 subjects. Diagn Pathol 2013;8:118
22. Zhang H, Zhu S, Chen J, et al. Peroxisome proliferator-Activated receptor gamma polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: Evidence from meta-Analysis of 18 studies. Diabetes Care 2012;35:1388-93